Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Casilda Llácer"'
Autor:
Nicolas Epaillard, Pauline Parent, Yohann Loriot, Pernelle Lavaud, E-B. Vera-Cea, Nieves Martinez-Chanza, Alejo Rodriguez-Vida, Clement Dumont, Rebeca Lozano, Casilda Llácer, Raffaele Ratta, Stephane Oudard, Constance Thibault, Edouard Auclin
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionLess than one-third of bladder cancers are non-pure urothelial carcinoma [with variant histological (VH) or non-urothelial carcinoma (non-UC)] for which no treatment guidelines are available. We aim to evaluate the efficacy of systemic tr
Externí odkaz:
https://doaj.org/article/ed8ecba51bbe460394392870f4cd0d98
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
David Olmos, Miguel Rodrigo, Carlos Di Capua, Guillermo Velasco, Carlos Ferrer, David Lorente, Rebeca Lozano, Ángel Sánchez-Iglesias, Elena Castro, Nuria Romero-Laorden, Casilda Llácer, Alfredo Sanchez-Hernandez
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
Instituto de Salud Carlos III (ISCIII)
Most available prognostic nomograms in metastatic castration-resistant prostate cancer (mCRPC) are derived from datasets not representative of the current treatment landscape. A prognostic nomogram for first-line mCRPC treatment was developed from pa
Autor:
Javier Puente, E. Almagro, Rebeca Lozano, David Lorente, Belen Gonzalez, Amaia Hernandez, Raquel Luque, Carlo Cattrini, Esther Martínez, Josep M. Piulats, Francisco Zambrana, Casilda Llácer, Elena Castro, Fernando López-Campos, Alejo Rodriguez-Vida, Ana Medina, R. Villatoro, Montserrat Domenech, Nuria Lainez, David Olmos, Nuria Romero-Laorden, María José Méndez-Vidal
Publikováno v:
European Urology. 77:763-766
Autor:
Rebeca Lozano, David Olmos, Adam Sharp, Penelope Flohr, Pasquale Rescigno, Alison Reid, Casilda Llácer, Ylenia Cendon, Teresa Garcés, Joaquim Mateo, Maria I Pacheco, Elena Castro, Isabel M. Aragón, Shahneen Sandhu, David Lorente, Pedro P. López-Casas, Christophe Massard, Diletta Bianchini, Nuria Romero-Laorden, Paz Nombela, Johann S. de Bono
Publikováno v:
Cancers
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Banco de España
Cancers, Vol 13, Iss 2334, p 2334 (2021)
Volume 13
Issue 10
Scientia
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Banco de España
Cancers, Vol 13, Iss 2334, p 2334 (2021)
Volume 13
Issue 10
Scientia
Circulating tumor cell (CTC) enumeration and changes following treatment have been demonstrated to be superior to PSA response in determining mCRPC outcome in patients receiving AR signaling inhibitors but not taxanes. We carried out a pooled analysi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aab567628c189bece86d7269a3266b7
https://fundanet.fhpcs.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1350
https://fundanet.fhpcs.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1350
Autor:
Casilda Llácer, Heather Thorne, José Rubio-Briones, David Lorente, Rebeca Lozano, Pedro P. López-Casas, Emmanuel S. Antonarakis, Fernando López-Campos, Tamara L. Lotan, Francisco Zambrana, Colin C. Pritchard, Teresa Garcés, Alejandro Sanz, Nuria Romero-Laorden, Ana M. Gutierrez-Pecharroman, David Olmos, Laneisha Maldonado, Isabel M. Aragón, Isabel García, Shahneen Sandhu, Juan Daniel Prieto, Elena Castro, Joaquin Mateo, Tomas di Domenico, Maria I Pacheco, Daniela C. Salles
Publikováno v:
European Journal Of Cancer
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Banco de España
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Banco de España
Background: Intraductal (IDC) and cribriform (CRIB) histologies in prostate cancer have been associated with germline BRCA2 (gBRCA2) mutations in small retrospective series, leading to the recommendation of genetic testing for patients with IDC in th
Autor:
David William Pook, Daniel M. Geynisman, Joan Carles, Filippo G. De Braud, Anthony M. Joshua, Jose Luis Perez-Gracia, Casilda Llácer Pérez, Sang Joon Shin, Bruno Fang, Minal A. Barve, Marco Maruzzo, Sergio Bracarda, Miso Kim, Yannick Kerloeguen, Jorge Daniel Gallo, Sophia Maund, Adam Harris, Kuan-Chieh Huang, Dhruvitkumar S. Sutaria, Howard Gurney
Publikováno v:
Journal of Clinical Oncology. 40:95-95
95 Background: mCRPC remains an incurable disease with unmet need for improved therapies. PARP inhibition has demonstrated antitumor activity, and preclinical studies suggest synergy between PARP and AKT inhibition. This phase Ib trial (NCT03840200)
Autor:
L. Perez-Villa, Casilda Llácer, Luis Vicioso, Cristina E. Fernandez-De Sousa, César L Ramírez-Tortosa, Jose Miramon, Irene Zarcos, Vanessa de Luque, José M. Jerez, Martina Alvarez, Julio Montes-Torres, Alfonso Sánchez-Muñoz, Angela Santonja, Yessica Plata-Fernández, Emilio Alba
Publikováno v:
Modern Pathology. 31:299-306
Male breast cancer is a rare disease that is still poorly understood. It is mainly classified by immunohistochemistry as a luminal disease. In this study, we assess for the first time the correlation between molecular subtypes based on a validated si
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Begona Jimenez, Rodriguez, Gema Diaz, Córdoba, Alicia Garrido, Aranda, Martina, Álvarez, Luis, Vicioso, Casilda Llácer, Pérez, Cristina, Hernando, Begoña, Bermejo, Ana Julve, Parreño, Ana, Lluch, Matthew B, Ryder, Frederick S, Jones, Johannes, Fredebohm, Frank, Holtrup, María Isabel, Queipo-Ortuño, Emilio, Alba
Publikováno v:
Journal of Clinical Medicine
Circulating tumor DNA (ctDNA) has emerged as a non-invasive “liquid biopsy” for early breast cancer diagnosis. We evaluated the suitability of ctDNA analysis in the diagnosis of early breast cancer after mammography findings, comparing PIK3CA and